PDCD1 and melanoma: In contrast, our statistical analysis suggested that the overall incidence of pneumonitis related with PD-1 inhibitors was actually much lower in melanoma patients than many other tumor types, implicating a wide safety range of PD-1 inhibitors in melanoma treatment.